University of California, San Diego
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Diego sits in the top decile of US sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count).
University of California, San Diego: 775 sponsored US clinical trials, 143 recruiting.
University of California, San Diego sponsors 775 registered US clinical trials on ClinicalTrials.gov, 143 of them currently recruiting, and 499 completed. 104 of these trials are in Phase 3-4 (later-stage) and 170 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anorexia Nervosa, with 10 trials.
Top-decile sponsor footprint
University of California, San Diego ranks in the top decile of sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
499 of 553 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
775 total, page 14 of 16
Perineural Catheter Insertion Distance for Continuous Peripheral Nerve Blocks
NCT00997867
Examination of the Anti-inflammatory and Insulin Sensitizing Properties of Doxycycline in Humans
NCT01375491
Effect of Pimecrolimus Cream on Cathelicidin Levels in Subjects With Eczema
NCT00946478
Guided Self-help for Families With an Overweight Child
NCT01145833
Seamos Saludables - Physical Activity Intervention Study for Latinas
NCT01583140
Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung Metastases
NCT01114958
Treatment of Surgical Scars Using the Pulsed Dye Laser
NCT00970671
Complementary & Alternative Medicine Use in HIV+ Latinos in the US-Mexico Border
NCT01152684
Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome
NCT00989781
Femoral Versus Psoas Continuous Peripheral Nerve Blocks Following Hip Arthroplasty
NCT00967980
Ezetimibe in Patients Hypo-responsive to Statins
NCT00965055
Alemtuzumab and Clofarabine for Relapsed or Refractory Acute Lymphoblastic Leukemia
NCT00983528
Burden of Obstructive Sleep Apnea in Stroke (BOSAST)
NCT00952211
Continuous Transversus Abdominis Plane Nerve Block for Postoperative Analgesia
NCT00944151
Stroke Team Remote Evaluation Using a Digital Observation Camera- Long Term Outcomes(STRokE DOC-LTO)
NCT00936455
Role of Parenting Skills and Parenting Style in Pediatric Weight Loss Programs
NCT01004341
Functional Magnetic Resonance Imaging (fMRI) Imaging Study in Adolescents With Anorexia Nervosa
NCT00978666
The Dynamics of Human Atrial Fibrillation
NCT01008722
Optimizing Local Anesthetic Concentration for Continuous Femoral Nerve Blocks
NCT00923598
Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
NCT01397695
A Study of Dasatinib and Rituximab for Relapsed/Refractory Chronic Lymphocytic Leukemia
NCT00949988
Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease
NCT00760435
Neurobiology of Anorexia and Bulimia Nervosa
NCT04626219
Telephone Counseling and the Distribution of Nicotine Patches to Smokers
NCT00851357
Trial of Maintenance Therapy With Posterior Tibial Nerve Stimulation for Overactive Bladder
NCT00912314
Oxytocin Add-on Study for Stable Anxiety Patients
NCT00989937
Optimization of Catheter Insertion Site for Continuous Peripheral Nerve Blocks
NCT00876746
UCSD Q10 and Aging Study
NCT02012322
CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery
NCT00925756
Ambulatory Continuous Peripheral Nerve Blocks for Treatment of Post-Amputation Phantom Limb and Stump Pain
NCT00667264
Naval Medical Center San Diego (NMCSD) - Ambulatory Continuous Peripheral Nerve Blocks for Treatment of Post-Amputation Phantom Limb and Stump Pain
NCT00768248
Prevention of Phantom Limb and Stump Pain Using Ambulatory Continuous Peripheral Nerve Blocks: A Pilot Study
NCT00771862
Predictors of Ovarian Insufficiency in Young Breast Cancer Patients
NCT01197456
Memory Consolidation in Pharmacologically Enhanced Naps
NCT00777829
Kelee® Meditation: A Distinctive and Effective Therapeutic Intervention for Stress, Anxiety, and Depression
NCT01527955
Shoulder Adhesive Capsulitis and Ambulatory Continuous Interscalene Nerve Blocks
NCT00875862
Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine in Treatment Naive Patients
NCT00752856
Lung Protective Ventilation in Pulmonary Thromboendarterectomy (PTE) Patients
NCT00747045
PACE-CALL: A Weight Control Intervention for Survivors of Childhood Leukemia
NCT01171599
Neuropsychiatric Effects of Deep Brain Stimulation in Patients With Parkinson's Disease
NCT01306539
Q10 for Gulf War Veterans
NCT01011348
Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study)
NCT00147966
PharmacofMRI of Anxiolytic Medications (Pregabalin)
NCT00706836
Testing Health Games for Adolescent Physical Activity
NCT01171261
Optimizing Local Anesthetic Concentration for Continuous Lumbar Plexus Nerve Blocks
NCT00912873
Study EvAluating Genotypes While Using Lucentis 2
NCT01464723
Sex Differences in Gene Expression in Human Adipose Tissue
NCT00677651
Cognitive Training to Improve Work Outcomes in Severe Mental Illness
NCT00895258
Reducing CVD Risk in Caregivers: A Brief Behavioral Activation Intervention
NCT01802554
Ultrasound Guidance Versus Electrical Stimulation for Continuous Popliteal-Sciatic Nerve Blocks
NCT00876681
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 80 |
| Phase 2 | 90 |
| Phase 3 | 22 |
| Phase 4 | 82 |
Therapeutic Areas
What is open in the University of California, San Diego pipeline
143 recruiting of 775 indexed (18% open); 499 completed (64%).
Phase mix: 104 late (III/IV) vs 170 early (I/II) (early-phase heavy).
Top condition: Anorexia Nervosa (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Diego: open-pipeline peers nationwide
Peers matched on 775 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of California, San Diego sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 775 trials (± recruiting share)
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- Medical University of South Carolina · 755 trials · 19% recruiting
- University of Chicago · 796 trials · 20% recruiting
- University of Utah · 818 trials · 17% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Neurocrine Biosciences · 18% recruiting · 65 trials
- Thomas Jefferson University · 18% recruiting · 292 trials
- Abramson Cancer Center at Penn Medicine · 18% recruiting · 402 trials
- University of Maryland, Baltimore · 18% recruiting · 560 trials
Related
What to do with this University of California, San Diego page
775 registered trials is a research-attention snapshot, not an endorsement of University of California, San Diego or any single study.
- 143 of University of California, San Diego's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Anorexia Nervosa is the condition University of California, San Diego studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anorexia Nervosa trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Diego pipeline card: 775 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.